Find Academic Supervisors

William JacksonView profile

Professor

• Cardiovascular Pharmacology
• Ion Channel Biology
• Vascular Physiology
• +5 more

Dr. William Jackson is a Professor in the Department of Pharmacology & Toxicology at Michigan State University (MSU), affiliated with the College of Osteopathic Medicine. He completed his B.S. (Zoology, 1974), M.S. (Physiology, 1976), and Ph.D. (Physiology, 1979) at MSU, followed by postdoctoral training at the University of Virginia. His career includes academic roles at Western Michigan University (1989–2005) and the Medical College of Georgia (1983–1989). He leads the online Professional Science Master’s program in Integrative Pharmacology since 2005. Research focuses on ion channel regulation of vascular tone, particularly myogenic responses and oxygen signaling in microcirculation. Key areas include hypertension, aging effects, and disease impacts on arteriolar function. Notable contributions include identifying TRPV4 and K+ channel roles in cerebrovascular health and cognitive function. Teaching responsibilities include courses like PHM 830 (Experimental Design & Data Analysis) and PHM 802 (Cellular/Molecular Pharmacology). Awards include the Distinguished Faculty Scholar from WMU (1998). His work bridges pharmacology, physiology, and computational biology, with over 150 peer-reviewed articles addressing vascular pathophysiology mechanisms. Education: B.S. Zoology, MSU (1970–1974) M.S. Physiology, MSU (1974–1976) Ph.D. Physiology, MSU (1976–1979) Affiliations: Director, Online PSM Integrative Pharmacology Program Member, MSU Pharmacology & Toxicology faculty since 2005 Grants & Labs: NIH-funded studies on cerebral microvasculature Focus on translational research linking ion channels to clinical outcomes Publications emphasize mechanisms of vascular dysfunction in hypertension, aging, and neurodegenerative diseases, with recent work exploring sex-based differences in vascular resilience.

Maria FragiadakiView profile

Senior Lecturer

• Molecular Medicine
• Kidney Disease
• Cardiovascular Disease
• +4 more

Dr. Maria Fragiadaki is a Senior Lecturer at Queen Mary University of London (QMUL), affiliated with the William Harvey Research Institute (WHRI) within the Faculty of Medicine and Dentistry. She holds a UKRI Future Leaders Fellowship (2021–2027) and previously received a Kidney Research UK Intermediate Fellowship and an Academy of Medical Sciences Springboard Award. Her research focuses on understanding molecular pathways in kidney and cardiovascular diseases, particularly the role of RNA-binding proteins in cellular homeostasis. Education: PhD in Molecular Medicine (Imperial College London, 2009), BSc in Genetics (University of Aberdeen, 2005). Postdoctoral training at Imperial College London and the University of Sheffield MRC Centre for Biomedical Genetics. Research Interests: RNA-binding proteins (e.g., ANKHD1) in renal and cardiovascular disease. JAK/STAT signaling in polycystic kidney disease (PKD). Inflammatory drivers of PKD and atherosclerosis. Mechanosensing pathways in atherosclerosis. Funding & Collaborations: Supported by UKRI, British Heart Foundation, and Kidney Research UK. Collaborators include Prof. Sian Henson, Dr. Li Chan, and Prof. Chris Thiemermann. Teaching: Committed to training researchers at undergraduate, PhD, and postdoctoral levels.

Marina CariniView profile

Professor

• Pharmaceutical Chemistry
• Cosmetic Science
• Proteomics and Lipidomics
• +3 more

Marina Carini is a Full Professor in Pharmaceutical Chemistry at the University of Milan, where she directs significant research initiatives including the Postgraduate Course in Cosmetic Science and the Postgraduate Course in Cosmetic Products: from formulation to consumer. She previously served as Director of the Department of Pharmaceutical Sciences (2009-2017) and Chair of the Intradivisional Pharmaceutical Analysis Group. Currently, she oversees the Social Sustainability and UN 2030 Agenda project at Human Hall, demonstrating her commitment to societal impact beyond traditional academic boundaries. Her educational foundation includes a Pharmacy degree and specialization in Hospital Pharmacy. Professor Carini's research integrates pharmaceutical chemistry with advanced bioanalytical techniques, focusing on molecular mechanisms of disease through proteomic and lipidomic approaches. She employs cutting-edge methodologies including high-resolution mass spectrometry and artificial intelligence to investigate oxidative stress, inflammation, and natural product pharmacology. Analysis of her recent publications reveals a cohesive research trajectory centered on carnosine's protective effects against UV damage and COPD, phytochemical mechanisms in cardiovascular and inflammatory diseases, and innovative analytical platforms for natural product screening. Her work bridges fundamental biochemistry with clinical applications in dermatology, cardiology, and sustainable nutraceutical development. Her scientific contributions were recognized with the Sapio Prize for Italian Research in 2003. As arbiter of the Italian Society of Cosmetological Sciences, she shapes industry standards while mentoring through specialized postgraduate programs. Her leadership extends to coordinating multi-institutional projects addressing environmental contaminants in aquaculture and gender disparities in urological oncology. Professor Carini maintains an active research program through the Department of Pharmaceutical Sciences, where she continues to advance analytical methodologies for studying metabolic reprogramming in vascular dysfunction and developing sustainable phytochemical complexes from agricultural by-products. Her work demonstrates exceptional translational potential from bench to bedside and consumer applications.

David P. HustonView profile

Professor

• Immunobiology
• Allergic Inflammation
• Cytokine Regulation (TSLP, IL-5)
• +3 more

David P. Huston, MD, is a Professor in the Department of Microbial Pathogenesis & Immunology and Associate Dean/Director of the Clinical Science & Translational Research Institute at Texas A&M University School of Medicine. His research focuses on mechanisms regulating allergic inflammation, particularly cytokines like TSLP and IL-5, and mast cell activation. He leads NIH-funded studies on asthma pathogenesis and translational therapeutics. Dr. Huston holds leadership roles in the NIH Hypersensitivity Autoimmunity Study Section and the American Academy of Allergy, Asthma & Immunology. Education: Bachelor of Science (Biology), Wofford College (1969) Doctor of Medicine, Bowman Gray School of Medicine (1973) Research Interests: Dr. Huston's lab investigates cytokine signaling pathways in allergic diseases, with emphasis on TSLP as a master regulator of asthma pathobiology. His work integrates in vitro and clinical studies to develop therapies targeting eosinophils and mast cell interactions. Recent studies explore aerosolized TLR agonists for allergic inflammation suppression. Publications: His 2024 work includes biomaterial-based cancer vaccines and immune modulation platforms. 2023-2020 studies highlight TLR agonist therapies and IL-5 receptor signaling. Earlier research (2003–2019) addressed cytokine pathways in asthma and autoimmune disorders. Awards/Service: Medical Alumni Association Distinguished Achievement Award (2005) NIH Study Section Member Board Member: American Board of Internal Medicine & AAAAI Grants/Students: NIH/NIAID Asthma & Allergy Cooperative Research Center grant supports graduate and medical student training. His lab emphasizes translational research mentorship. Lab Activities: Focuses on preclinical models of allergic inflammation, cytokine receptor engineering, and biomaterial-based drug delivery systems for personalized immunotherapy.

Michael MorenoView profile

Associate Professor

• Biomechanics
• Medical Device Design
• 3D Bioprinting
• +3 more

Michael Moreno is Associate Professor of Mechanical Engineering at Texas A&M University's College of Engineering, holding the J. Mike Walker '66 Faculty Fellowship. He serves as Assistant Dean of Innovation for Engineering Medicine and is affiliated with Biomedical Engineering. Education: Ph.D. in Biomedical Engineering (Texas A&M, 2009), M.S. in Biomedical Engineering (Florida International University, 2003), M.S. in Science Education (Florida International University, 1997), B.S. in Physics (Florida International University, 1996). His biomechanics research spans medical device innovation, cardiovascular systems, orthopedic applications, and sports performance. Current projects include LVAD hemocompatibility, 3D bioprinting, and motion analysis in veterinary contexts. Moreno's publications reflect cross-disciplinary approaches to medical challenges, with recent emphasis on computational modeling in orthopedics, innovative surgical techniques, and performance optimization in athletics. Technical developments include novel bioreactor systems and constitutive bone models. Dean of Engineering Excellence Award (2016) TEES Young Faculty Fellow Award (2016) ASME Bioengineering Division Skalak Award (2012) He leads research on cardiac compression devices and advises projects in sports biomechanics. Laboratory work includes custom instrumentation for soft tissue characterization and in vitro physiological simulation.

• Clinical Biochemistry
• Extracellular Vesicles
• Microvesicles
• +7 more

Morten Hjuler Nielsen is a Ph.D.-holding researcher at Aalborg University Hospital, affiliated with the Faculty of Medicine and the Department of Clinical Biochemistry. He is actively involved in research focusing on extracellular vesicles, microvesicles, and their roles in metabolic and cardiovascular diseases. His research interests include: Extracellular vesicles and microvesicles as biomarkers Familial hypercholesterolemia and cardiovascular risk CD36 and its role in metabolic syndrome Bilirubin metabolism and analytical methods Flow cytometry for vesicle characterization Monocyte phenotypes in inflammatory diseases The analysis of his recent publications reveals a consistent focus on extracellular vesicles as diagnostic and pathophysiological markers in conditions like non-alcoholic fatty liver disease (NAFLD), familial hypercholesterolemia, type 2 diabetes, and chronic kidney disease. His work integrates clinical biochemistry with immunology, emphasizing the role of cellular microparticles in inflammation and endothelial dysfunction. Methodologically, he specializes in flow cytometry and HPLC-based assays for precise biomarker quantification. Morten Hjuler Nielsen has delivered professional talks on microparticle characterization, indicating knowledge dissemination beyond academia. His collaborative work, especially with Aase Handberg, spans multiple disease areas, demonstrating interdisciplinary research engagement. He has contributed to the creation of research datasets, such as those related to bariatric surgery and CD36-bearing microvesicles, supporting open science practices.

• Pulmonary Fibrosis
• Lung Repair
• Epigenetic Mechanisms
• +3 more

Giovanni Ligresti is an Associate Professor at Boston University's Chobanian & Avedisian School of Medicine, affiliated with the Pulmonary Center. He holds a PhD from the University of Trieste and mentors graduate students in medical sciences. His research focuses on molecular mechanisms of lung repair and pulmonary fibrosis, particularly the role of epigenetic modifiers like CBX5 and G9a in fibroblast activation. He investigates how aging impacts vascular dysfunction and persistent fibrosis, using multi-omics approaches including RNA-seq and scRNA-seq. Ligresti leads NIH-funded grants targeting vascular dysfunction and epigenetic pathways in fibrosis. His work bridges basic science and translational medicine, addressing key questions in fibrotic disease mechanisms and therapeutic strategies. Education: PhD, MS, BS in Biology from University of Trieste. Research Interests: Lung fibrosis, epigenetic regulation, aging mechanisms, vascular biology, and regenerative medicine. Key projects include identifying therapeutic targets for idiopathic pulmonary fibrosis and understanding aging-associated fibrosis through endothelial cell dysfunction. Grants: Principal Investigator (PI) on NIH R01 grants (HL158733, HL142596) and industry funding from Ono Pharmaceutical. Subcontract PI on NHLBI-funded research. Labs/Teams: Leads labs at the Pulmonary Center, collaborating with teams on lung injury models and omics-based discovery.

• Infectious Diseases
• Malaria
• Immunogenetics
• +7 more

Dr. Arnoldo Barbosa is a prominent researcher in infectious diseases, particularly malaria, with affiliations including the Centro de Investigação em Saúde de Manhiça (CISM), Instituto de Salud Global de Barcelona, Hospital Clínic de Barcelona, and Universitat de Barcelona. His work bridges immunology, genetics, and global health, focusing on pediatric populations in malaria-endemic regions of Africa. His research explores the genetic and immunological determinants of malaria susceptibility, with emphasis on cytokine profiles, TLR polymorphisms, antibody responses, and vaccine immunogenicity. Key areas include host-pathogen interactions , maternal-fetal malaria transmission , and immune regulation in children . He has extensively studied the RTS,S malaria vaccine and biomarkers of protection. The trend in his recent publications reflects a deepening focus on genetic susceptibility , immune balance , and diagnostic or protective biomarkers in malaria. His use of advanced technologies like multiplex cytokine assays and genetic association studies underscores his methodological rigor. Dr. Barbosa's research has been supported by major international sponsors such as the National Research Foundation, National Natural Science Foundation of China, King Saud University, United Arab Emirates University, and the British Council, highlighting the global relevance and collaborative nature of his work. He has contributed to leading journals including Malaria Journal , Infection and Immunity , Clinical Infectious Diseases , and The Lancet . While no formal awards are listed, his high citation count (348), H-index of 28, and 28 publications in top-tier journals affirm his academic influence. He has likely mentored junior researchers through large-scale collaborative studies, though specific students are not named. His work is primarily conducted through research centers such as CISM and the Barcelona Institute for Global Health, which serve as hubs for malaria epidemiology, vaccine trials, and immunological surveillance in sub-Saharan Africa.

Aleksandar Stanic-KosticView profile

Associate Professor

• Reproductive Immunology
• Maternal-Fetal Interface
• Immunology
• +5 more

Aleksandar Stanic-Kostic is an Associate Professor at the University of Wisconsin-Madison School of Medicine and Public Health, Department of Obstetrics and Gynecology, with dual appointments in the Divisions of Reproductive Endocrinology and Infertility and Reproductive Sciences. He serves as a physician-scientist at Generations Fertility Care and Meriter Hospital, specializing in female infertility, recurrent pregnancy loss, and in vitro fertilization (IVF) challenges. Education: Undergraduate: University of Novi Sad, Yugoslavia (1998) M.D./Ph.D.: Vanderbilt University School of Medicine (2000-2006) Postdoctoral Fellowship: Vanderbilt University School of Medicine Residency: Brigham and Women’s Hospital/Harvard Medical School (2006-2010) Fellowship: Massachusetts General Hospital/Harvard Medical School (2011-2014) Dr. Stanic-Kostic’s research focuses on reproductive immunology, particularly the role of innate lymphoid cells and immune networks in maternal-fetal interface organization. His lab investigates conditions like preeclampsia, intrauterine growth restriction, recurrent pregnancy loss, and implantation failure in assisted reproductive technologies (ART) using human and murine models with genetic targeting. Collaborations with biostatisticians and computer scientists enable advanced analysis of high-dimensional flow cytometry data to model reproductive immune networks. His recent work includes proteogenomic and single-cell RNA sequencing studies on decidual T cells and MAIT cells, cytokine signaling in placental development, and immune dysregulation in polycystic ovary syndrome (PCOS). Awards include the NIH/ Mead Johnson Early Career Investigator Award, Basil O’Connor Scholar Award, Preterm Birth Initiative Award, and the Best Poster Award at the American Society for Reproductive Immunology (ASRI) Conference. Dr. Stanic-Kostic has secured grants such as the NIH R21 and Wisconsin National Primate Research Center pilot grant. He mentors graduate students and postdoctoral trainees, including Andrea Killian Wegrzynowicz and Soma Banerjee, and leads sessions on evidence-based management of recurrent pregnancy loss at major conferences like ASRM and ASRI.

• Cell and Molecular Biology
• Physiology
• Vascular Biology
• +12 more

Havovi Chichger is a Professor in Biomedical Science at Anglia Ruskin University, where she is also Deputy Head of School (Research, Innovation & Income Generation) in the School of Life Sciences, Faculty of Science and Engineering. Her research is conducted within the Medical Technology Research Centre and Vision and Eye Research Institute, and she is affiliated with the Cambridge Cardiovascular Interdisciplinary Research Centre. PhD in Physiology, University College London Postdoctoral Fellow, Brown University PGCert in Higher Education and Learning, Anglia Ruskin University BSc in Biochemistry, King’s College London Her research centers on the molecular mechanisms of endothelial and epithelial physiology, particularly in the context of diabetes and pulmonary diseases. Key areas include the physiological roles of bitter and sweet taste receptors (T1R3, T2Rs), endosomal trafficking (via Rab GTPases, p18), and signaling pathways (PKC, MAPK, SHP2) in regulating vascular and epithelial barrier function. She investigates how artificial sweeteners, gut microbiota, and environmental factors like e-cigarettes impact these systems. Her work bridges cell and molecular biology with translational applications in diabetic complications and acute lung injury. Her recent publications reveal a strong thematic focus on the dual role of artificial sweeteners—both as potential disruptors of gut and lung barriers and as unexpected protectors in microvascular complications. She also explores natural compounds like olive polyphenols for exercise recovery and lung cancer therapeutics. The research consistently employs in vitro models of endothelial and epithelial cells to dissect molecular pathways. American Heart Association Postdoctoral Fellowship Teaching Excellence Certificate, Sheridan Centre, Brown University Fellow, Higher Education Academy Editor, Experimental Physiology Member, Editorial Board, Lung Cellular and Molecular Biology Member, Scientific Conference Committee, The Physiological Society Havovi Chichger actively supervises multiple PhD students, including Lewis Spurrier-Best (lung injury), Emily Capes (platelet zinc release), and Mary Bishop-Strutt (glioblastoma treatment). Her research is supported by substantial grants from the British Heart Foundation, Wellcome Trust, Diabetes UK, Cambridge Philosophical Society, and commercial partners, totaling over £500k. She leads the Biomedical Research Group and holds a UK/USA patent related to food supplementation. She is a member of numerous professional societies including The Physiological Society, American Heart Association, American Physiological Society, and American Thoracic Society, and serves as an ad-hoc reviewer for over 12 journals. Her lab focuses on understanding novel regulators of microvascular complications and developing therapeutic strategies for vascular dysfunction in metabolic and respiratory diseases.

• Sepsis
• HIV
• Tropical Diseases
• +3 more

Jan Kristian Damås is a Professor at the Department of Clinical and Molecular Medicine at NTNU, affiliated with the Centre of Molecular Inflammation Research. He also serves as a Senior Physician in the Department of Infectious Diseases. His research focuses on sepsis, HIV, tropical diseases (e.g., scrub typhus), and cardiovascular pathologies. Key areas include inflammatory mechanisms, epidemiological trends, and clinical outcomes of infectious diseases. Publications emphasize machine learning applications for infection prediction, sepsis diagnosis accuracy, and long-term sepsis outcomes. Recent studies explore Mendelian randomization in urinary tract infections and endothelial dysfunction in myocardial infarction. Collaborations involve interdisciplinary teams examining cytokine profiles in HIV, immune modulation in STEMI patients, and public health aspects of sepsis coding practices. His work bridges clinical practice and basic science, addressing translational challenges in infectious disease management. Ongoing projects include studies on insomnia’s role in sepsis risk and genetic determinants of infection susceptibility.

Tara L. HaasView profile

Professor

• Angiogenesis
• Vascular Biology
• Endothelial Cell Biology
• +13 more

Tara L. Haas is a Full Professor in the Department of Biology within the Faculty of Science at York University. She is eligible to supervise graduate students in the Biology Graduate Program and leads an active research laboratory focused on vascular biology and angiogenesis. Her research centers on the molecular regulation of angiogenesis in skeletal muscle and adipose tissue, particularly in the contexts of exercise, obesity, diabetes, and peripheral artery disease. A key focus is the role of the transcription factor FoxO1 in suppressing endothelial cell proliferation and metabolism, which contributes to impaired vascular function in metabolic and ischemic conditions. Her work combines molecular, physiological, and transcriptomic approaches to uncover mechanisms that could lead to novel therapeutic strategies. The recent publications highlight themes in sex-specific vascular responses, microvascular remodeling, leptin signaling, and metabolic regulation of angiogenesis. These studies employ mouse models and molecular techniques to explore how vascular adaptation is impaired or enhanced under disease conditions. Dr. Haas has made significant contributions to understanding the role of endothelial metabolism in tissue health. Her work bridges physiology, molecular biology, and metabolic disease research. She collaborates with researchers across disciplines, as evidenced by co-authorship on studies involving transcriptomics, metabolic phenotyping, and vascular imaging. While no formal awards are listed, her publications in high-impact journals such as eLife , Acta Physiologica , and iScience reflect strong scholarly impact. She advises graduate students and leads a research laboratory investigating vascular adaptation mechanisms.

Alberto MarzoView profile

Senior Lecturer

• Computational Fluid Dynamics
• Cardiovascular Biomechanics
• Medical Device Optimization
• +5 more

Dr. Alberto Marzo is a Senior Lecturer in the Department of Mechanical Engineering at the University of Sheffield, serving as Director of the MSc Bioengineering program. His research focuses on computational fluid mechanics, cardiovascular biomechanics, and clinical translation of engineering technologies. He holds a five-year Mechanical Engineering degree from the University of Cagliari, Italy, and a PhD from the University of Sheffield. Early in his PhD, he received the David Crighton Fellowship, enabling collaborative research at the University of Cambridge on flow-induced oscillations in elastic vessels. Education: Bachelor's/Master's (5-year): Mechanical Engineering, University of Cagliari, Italy PhD: University of Sheffield Research Interests: Image-based 3D cardiovascular modeling 1D whole-circulation blood flow modeling Medical device optimization (e.g., respiratory treatments) Hemodynamic influences on cardiovascular/biofilm dynamics High-performance computing (HPC) and statistical emulators for validation Recent Work Trends: His publications emphasize clinical translation, such as developing open-source tools (e.g., openBF solver), optimizing stroke treatment protocols, and integrating machine learning with biomechanics for diagnostic biomarkers. He also focuses on musculoskeletal modeling and renal artery hemodynamics. Awards: David Crighton Fellowship (2011) Grants & Leadership: Co-investigator in VPH-DARE@IT (EU FP7) for dementia modeling Principal Investigator for NHS/EPSRC urinary drainage system project Lead of CompBioMed EU H2020 Center of Excellence Teaching & Labs: Teaches courses like MEC320 (Computational Fluid Dynamics) and oversees labs focused on cardiovascular biomechanics and computational modeling.

Maj Schneider ThomsenView profile

Associate Professor

• Blood-Brain Barrier
• Gene Therapy
• Neurodegeneration
• +3 more

Maj Schneider Thomsen is an Associate Professor in the Department of Health Science and Technology at Aalborg University, affiliated with The Faculty of Medicine. Her research focuses on the blood-brain barrier (BBB), neurodegeneration, and drug delivery, particularly using gene therapy and nanoparticle strategies. She is part of the Neuroboost research team and has supervised two PhD students. Her work includes projects like the 2019-2021 project targeting therapies in hypoxic and inflamed BBB contexts. Institution: Aalborg University, Department of Health Science and Technology Research Themes: BBB integrity, gene therapy, neurodegenerative diseases, and translational drug delivery Key research interests include developing BBB-targeted therapies for conditions like Niemann-Pick type C and Alzheimer’s disease. Her recent work explores AAV-BR1 gene therapy efficacy in mouse models, BBB vascularity changes in neurodegeneration, and inflammatory responses in brain capillary cells. She has published extensively since 2014, with notable contributions in Fluids and Barriers of the CNS and Neurobiology of Disease . Awards: Not explicitly listed in provided texts, but her research has garnered media attention and has been cited in multiple peer-reviewed journals.

Lelinh DuongView profile

Research Fellow

• Ageing Immunology
• Macrophage Biology
• Cancer Research
• +3 more

Lelinh Duong is an early career Research Fellow at the University of Western Australia (UWA), focusing on ageing immunology and macrophage biology . She earned her PhD in Immunology (2024) and BSc(Hons) from Curtin University, researching mechanisms of macrophage dysfunction in elderly tumour microenvironments. Previously, she held roles including Associate Lecturer, Research Officer, and Sessional Academic at Curtin University (2019–2023). Her research explores how ageing impacts immune responses, particularly in cancer contexts. She investigates macrophage dysfunction in tumour environments and has expanded into studying drug allergies and plastic exposure effects on health. Key areas include mesothelioma, CSF-1 receptor signaling, and iron homeostasis in the brain during ageing. Dr. Duong’s work contributes to UN Sustainable Development Goals related to health and environmental sustainability. She is part of the Lucas Group at UWA, advancing interdisciplinary research on immunology and environmental health.